Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosa
Description
The worldwide emergence of carbapenem-resistance is a growing concern, particularly among Pseudomonas aeruginosa isolates.1 This microorganism display a large arsenal of resistance mechanisms which can contribute for the carbapenem-resistance